MedMe Health
Pharmacy software for clinical services workflows
Website: https://www.medmehealth.com/us
Cover Block
| Attribute | Value |
|---|---|
| Company Name | MedMe Health |
| Tagline | Pharmacy software for clinical services workflows |
| Headquarters | Toronto, Canada |
| Founded | 2019 |
| Stage | Seed |
| Business Model | SaaS |
| Industry | Healthtech |
| Technology | Software (Non-AI) |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (3+) |
| Funding Label | Seed |
| Total Disclosed Funding | $2.7M (2022 seed round) [PRWeb, 2022] |
Links
- Website: https://www.medmehealth.com/
- LinkedIn: https://ca.linkedin.com/company/medme-health
The Short Version
MedMe Health is building a software platform to help pharmacies in the United States and Canada move beyond dispensing medication to offering billable clinical services, a transition that represents a significant revenue diversification opportunity for a traditionally retail-focused industry [MedMe Health, Unknown]. The company's core product addresses a clear operational gap, providing tools for appointment scheduling, patient intake, clinical documentation, and billing for services like vaccinations and minor ailment assessments [MedMe Health Help Center, Unknown]. This focus on workflow efficiency and compliance aims to be the wedge into a pharmacy's operations.
Founded in 2019, the company was part of Y Combinator's Winter 2021 batch [MedMe Health blog, 2021]. The founding team combines healthcare operations and technical backgrounds, with CEO Purya Sarmadi holding a Master's in Health Informatics from the University of Toronto and co-founders Nicholas Hui and Rui Su recognized on the Forbes 30 Under 30 Healthcare list [MaRS Impact Health, Unknown] [LinkedIn, Unknown]. The company has raised a seed round, with M12 (Microsoft's venture fund) leading a $2.7 million investment in 2022 [PRWeb, 2022].
Data Accuracy: YELLOW -- Core product description and YC participation are well-sourced; funding amount and lead investor are confirmed by a single press release; team background and Forbes recognition are cited but from limited sources.
Taxonomy Snapshot
| Axis | Classification |
|---|---|
| Stage | Seed |
| Business Model | SaaS |
| Industry / Vertical | Healthtech |
| Technology Type | Software (Non-AI) |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (3+) |
| Funding | Seed |
The Company in Brief
MedMe Health was founded in 2019 in Toronto, Canada, by Purya Sarmadi, Nicholas Hui, and Rui Su [Crunchbase]. The company's origin aligns with a broader trend of expanding the pharmacist's role beyond dispensing medication into clinical services. A key early milestone was acceptance into Y Combinator's Winter 2021 cohort [MedMe Health blog, 2021]. This was followed by a publicly disclosed seed round in 2022, led by Microsoft's venture fund M12, which raised $2.7 million [PRWeb, 2022]. The company has since positioned its software as an operating system for pharmacies aiming to scale clinical services, citing a footprint that helped over 4,000 Canadian pharmacies serve more than 25 million patients [Forbes, 2023].
Data Accuracy: YELLOW -- Founding date and team confirmed by Crunchbase; funding round and accelerator participation corroborated by company blog and press release. The patient/pharmacy reach metric is a single-sourced claim.
What They Have Built
MedMe Health's product is a software platform designed to shift a pharmacy's role from a retail dispenser to a clinical service provider. The company's website and help center describe a system built around appointment scheduling, patient intake, documentation, and billing for a range of clinical programs [MedMe Health, Unknown]. These programs include flu vaccinations, COVID-19 services, minor ailment assessments, and virtual care [MedMe Health Help Center, Unknown].
A key component is the digital patient intake form. The platform also supports enterprise-level features like white-labeling and multi-store management [MedMe Health, Unknown]. Public integrations, such as a partnership with virtual care provider Telemed MD for travel health services and with MAPflow for minor ailment assessments, suggest a strategy of connecting pharmacies to external clinical networks [MedMe Health Help Center, Unknown] [MedMe Health, Unknown].
Data Accuracy: YELLOW -- Product features are described on the company's own site and help center, but third-party validation of deployment or technical specifications is limited.
Market Research and Opportunity
The market for pharmacy clinical services software is being reshaped by a structural shift in healthcare delivery, moving routine care out of overloaded primary care clinics and into retail pharmacy locations. In the United States, there are approximately 88,000 retail pharmacy locations [National Association of Chain Drug Stores, 2023]. The global pharmacy management systems market was valued at an estimated $25 billion in 2023, with a compound annual growth rate projected near 10% through 2030 [Grand View Research, 2023].
| Metric | Value |
|---|---|
| US Pharmacy Locations | 88000 locations |
| Global Pharmacy Systems Market (2023) | 25 $B |
| Projected Market CAGR | 10 % |
Data Accuracy: YELLOW -- Market size figures are from third-party industry reports for analogous sectors; pharmacy location count is a standard industry statistic.
Who Else Is Fighting for This
MedMe Health operates in a competitive space defined by legacy pharmacy management systems and a newer wave of software focused on clinical service enablement. A competitive map for pharmacy workflow software can be segmented into three tiers. First, the broad incumbent pharmacy management systems (PMS) like QS/1, PioneerRx, and McKesson's EnterpriseRx. Second, a newer category of point solutions and platforms built specifically for clinical workflow and revenue diversification, where MedMe appears to sit. Third, adjacent substitutes include general-purpose healthcare scheduling and telehealth platforms.
MedMe's potential edge today appears to be its singular focus on the clinical services wedge within the pharmacy [MedMe Health]. The team's healthcare operations background suggests an understanding of the regulatory and workflow complexities in this niche [MaRS Impact Health].
Data Accuracy: YELLOW -- Competitive analysis is inferred from product claims and market structure; no direct competitor comparisons are publicly cited.
Opportunity
The potential outcome for MedMe Health is the transformation of the North American retail pharmacy from a dispensing center into a primary care node, with its software as the required operating system for that transition. The company claims its software has already helped over 4,000 pharmacies serve more than 25 million patients [Forbes, 2023].
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Enterprise Standardization | A major national pharmacy chain adopts MedMe as its standard platform for clinical services rollout across all locations. | A successful pilot with a regional enterprise partner, demonstrating workflow efficiency and revenue lift. | The company explicitly targets enterprise pharmacies with features like white-labelling and multi-store management [MedMe Health]. |
| Regulatory Expansion | A new provincial or state regulation broadly expands pharmacist prescribing authority, creating immediate, widespread demand for compliant workflow tools. | Legislation passes, similar to minor ailments programs in Canada, mandating new documentation and patient management protocols. | The company's product already supports programs like minor ailments and virtual care [MedMe Health Help Center, Unknown]. |
| Ecosystem Anchor | MedMe's platform becomes the aggregation point for a network of third-party digital health services (labs, virtual physicians, insurers) integrated into the pharmacy workflow. | A strategic partnership with a large telehealth provider or payer to embed their services directly into the MedMe pharmacist interface. | The existing partnership with MAPflow for minor ailment assessments demonstrates a nascent ecosystem play [MedMe Health]. |
Data Accuracy: YELLOW -- Core market shift and product positioning are well-documented by the company. Growth scenario catalysts and compounding mechanisms are inferred from product features and partnerships.
Sources
- [MedMe Health, Unknown] Operating System for Pharmacies of the Future | https://www.medmehealth.com/
- [MedMe Health Help Center, Unknown] Home | MedMe Health Help Center | https://helpcenter.medmehealth.com/en/
- [MedMe Health blog, 2021] MedMe Health Joins Y Combinator (W21) | https://www.medmehealth.com/blog/medme-health-joins-y-combinator-w21
- [Crunchbase, Unknown] MedMe Health - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/medme-health
- [MaRS Impact Health, Unknown] Purya Sarmadi - MaRS Impact Health | https://www.marsdd.com/people/purya-sarmadi/
- [LinkedIn, Unknown] Purya Sarmadi - Co-Founder & CEO at MedMe Health (W21) | https://ca.linkedin.com/in/purya
- [PRWeb, 2022] Microsoft's M12 Leads $2.7M Seed Round in MedMe Health | https://www.prweb.com/releases/2022/10/prweb18968294.htm
- [Forbes, 2023] MedMe Health | https://www.forbes.com/profile/medme-health/
- [National Association of Chain Drug Stores, 2023] 2023 Chain Pharmacy Industry Profile | https://www.nacds.org/resources/industry-profile/
- [Grand View Research, 2023] Pharmacy Management System Market Size Report, 2023-2030 | https://www.grandviewresearch.com/industry-analysis/pharmacy-management-system-market
Articles about MedMe Health
- MedMe Health Puts Clinical Workflow on 4,000 Canadian Pharmacies — The YC-backed startup is betting that software for flu shots and minor ailments can turn retail pharmacies into primary care hubs.